Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
Public ClinicalTrials.gov record NCT00087581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Versus Concentration Controlled Cellcept® Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors
Study identification
- NCT ID
- NCT00087581
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 720 participants
Conditions and interventions
Conditions
Interventions
- Cyclosporine Drug
- Mycophenolate mofetil Drug
- Tacrolimus Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Aug 31, 2007
- Completion
- Aug 31, 2007
- Last update posted
- Nov 6, 2016
2004 – 2007
United States locations
- U.S. sites
- 57
- U.S. states
- 29
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Bakersfield | California | 93309 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | San Francisco | California | 94143-0116 | — |
| Not listed | Denver | Colorado | 80262 | — |
| Not listed | Gainesville | Florida | 32610-0224 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Miami | Florida | 33101 | — |
| Not listed | Orlando | Florida | 32804 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Indianapolis | Indiana | 46202-5124 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Lexington | Kentucky | 40536-0293 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Shreveport | Louisiana | 71130 | — |
| Not listed | Baltimore | Maryland | 21287-8611 | — |
| Not listed | Boston | Massachusetts | 02111 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Burlington | Massachusetts | 01805 | — |
| Not listed | Springfield | Massachusetts | 01107 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Ann Arbor | Michigan | 48109-0362 | — |
| Not listed | Detroit | Michigan | 48202-2689 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Hackensack | New Jersey | 07601 | — |
| Not listed | Livingston | New Jersey | 07039 | — |
| Not listed | Buffalo | New York | 14203 | — |
| Not listed | Hawthorne | New York | 10532 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Rochester | New York | 14642-8410 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Fargo | North Dakota | 58122 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Harrisburg | Pennsylvania | 17101 | — |
| Not listed | Hershey | Pennsylvania | 17033 | — |
| Not listed | Philadelphia | Pennsylvania | 19102-1192 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Pittsburgh | Pennsylvania | 15212 | — |
| Not listed | Providence | Rhode Island | 02903 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | San Antonio | Texas | 78284 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Falls Church | Virginia | 22042-3300 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00087581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2016 · Synced May 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00087581 live on ClinicalTrials.gov.